Trade LONA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
LeonaBio, Inc. (LONA) is trading at US$6.43, up 4.30% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$72.41M. Over the past 52 weeks, LONA has traded between US$2.21 and US$14.21. On Syfe you can trade LONA with $0 commission and add it to your watchlist.
| Previous close | US$6.17 |
|---|---|
| Market cap | US$72.41M |
| 52-week range | US$2.21 – US$14.21 |
| Volume | 57.01K |
| Exchange | US |
LeonaBio, Inc.
LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Year: 2020
--Mizuho Trims Price Target on LeonaBio to $15 From $16, Keeps Outperform Rating
Aug 18, 11:04 AM · MT Newswires
LeonaBio Narrows Q2 Loss
Aug 14, 8:23 PM · MT Newswires
--Piper Sandler Initiates LeonaBio at Overweight
May 27, 10:42 AM · MT Newswires
LeonaBio, Inc. (LONA) stock is trading at US$6.43, +4.30% from the previous close of US$6.17.
The market cap for LeonaBio, Inc. (LONA) stock is approximately US$72.41M.
The 52-week high for LeonaBio, Inc. (LONA) stock is US$14.21.
The 52-week low for LeonaBio, Inc. (LONA) stock is US$2.21.
LeonaBio, Inc. (LONA) does not currently pay a dividend.
Stay on top of LONA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
